Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective

被引:5
|
作者
Setyawan, Juliana [1 ]
Fridman, Moshe [2 ]
Hodgkins, Paul [1 ]
Quintero, Javier [3 ]
Erder, M. Haim [1 ]
Katic, Bozena J. [1 ]
Harpin, Valerie [4 ]
机构
[1] Shire, 725 Chesterbrook Blvd, Wayne, PA 19087 USA
[2] AMF Consulting Inc, Los Angeles, CA USA
[3] Hosp Univ Infanta Leonor, Madrid, Spain
[4] Ryegate Childrens Ctr, Sheffield, S Yorkshire, England
关键词
ADHD; Children and adolescents; Treatment outcomes; Treatment satisfaction; Symptom impairment; Comorbidities;
D O I
10.1007/s12402-014-0143-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the association between those symptoms/behaviours of attention-deficit/hyperactivity disorder (ADHD) that were present at diagnosis and outcomes of treatment in children and adolescents in six European countries. Physicians abstracted clinical records from patients (6-17 years) diagnosed with ADHD between 2004 and 2007 and treated for >= 2 years. Physicians scored the severity of impairment for core ADHD symptoms and additional (non-core) ADHD symptoms/behaviours at diagnosis and estimated treatment adherence (defined as an estimated >80 % adherence on weekdays and >50 % adherence on weekends). Treatment modalities included pharmacological treatment, behavioural therapy, or both. Pharmacological treatment was further subclassified by medication class. The outcome, optimal treatment success (OTS), was defined as complete symptom control with high satisfaction with treatment. Multivariate logistic regression modelling examined the relationship between OTS and symptom impairment. Of 730 patients, 200 (27 %) achieved OTS. These patients were more likely to demonstrate lower impairment in non-core ADHD symptoms/behaviours and have fewer pre-existing comorbidities. They were also more likely to be adherent and engaged with treatment, with an explicit treatment goal to improve inattention/school performance. Neither core symptoms' severity nor treatment types were associated with OTS. OTS rates were low, with patients having less impairment of non-core ADHD symptoms/behaviours and fewer comorbidities more likely to achieve OTS. Potentially modifiable factors affecting OTS were as follows: treatment adherence, treatment engagement, and a treatment goal to improve inattention/school performance. These data suggest that there may be opportunities to optimize current treatment use, and develop new treatment strategies to improve core and non-core ADHD symptoms/behaviours.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 50 条
  • [1] Examining the relationship between Attention-Deficit/Hyperactivity Disorder and overweight in children and adolescents
    Erhart, Michael
    Herpertz-Dahlmann, Beate
    Wille, Nora
    Sawitzky-Rose, Barbara
    Hoelling, Heike
    Ravens-Sieberer, Ulrike
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2012, 21 (01) : 39 - 49
  • [2] Examining the relationship between Attention-Deficit/Hyperactivity Disorder and overweight in children and adolescents
    Michael Erhart
    Beate Herpertz-Dahlmann
    Nora Wille
    Barbara Sawitzky-Rose
    Heike Hölling
    Ulrike Ravens-Sieberer
    European Child & Adolescent Psychiatry, 2012, 21 : 39 - 49
  • [3] Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Carbray, Julie A.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (12) : 7 - 10
  • [4] Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
    Najib, Jadwiga
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 66
  • [5] Diagnosis and treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Brown, MB
    JOURNAL OF COUNSELING AND DEVELOPMENT, 2000, 78 (02): : 195 - 203
  • [6] Attention-deficit/hyperactivity disorder in children and adolescents
    Dunn, DW
    Kronenberger, WG
    NEUROLOGIC CLINICS, 2003, 21 (04) : 933 - +
  • [7] PHARMACOTHERAPEUTIC TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Regnart, J.
    McCartney, J.
    Truter, I
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 148 - 148
  • [8] Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Goldman, LS
    Genel, M
    Bezman, RJ
    Slanetz, PJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (14): : 1100 - 1107
  • [9] Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Greenhill, Laurence L.
    McNamara, Nora K.
    Demeter, Christine A.
    Kotler, Lisa A.
    O'Riordan, Mary Ann
    Myers, Carolyn
    Reed, Michael D.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 433 - 445
  • [10] Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder
    Leggett, Catherine
    Hotham, Elizabeth
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2011, 47 (08) : 512 - 517